I

    Inspire Medical Systems Inc (INSP)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $63.00
    +1.56 (+2.54%)

    Market Cap: $1.78B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    94%(32/34)
    Avg Surprise
    +101.89%
    Streak
    25 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.09
    Range$-0.13 - $0.17
    13 analysts
    EPS Revisions
    2
    0
    7d
    2
    8
    30d
    EPS Estimate Drift
    90d ago$0.18+110.2%
    60d ago$0.18+110.2%
    30d ago$0.15+73.3%
    7d ago$0.14+61.8%
    Current$0.09
    Revenue Consensus
    $204M
    Range$203M - $205M
    16 analysts
    Dec 31, 2026
    EPS Consensus$1.67
    Range$1.59 - $1.75
    14 analysts
    Revenue Consensus
    $255M
    Range$241M - $263M
    17 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.67---
    Sep 26EST
    		-$0.09---
    Jun 26
    		$0.14$-0.22+163.64%Beat-68.9%
    Mar 26
    		$0.10N/A+138.46%Beat+0.0%
    Dec 25
    		$1.65$0.68+142.65%Beat+43.5%
    Sep 25
    		$0.38$-0.17+323.53%Beat-36.7%
    Jun 25
    		$0.45$0.20+125.00%Beat+40.6%
    Mar 25
    		$0.10N/A+143.48%Beat+129.4%
    Dec 24
    		$1.15$0.72+59.72%Beat+134.7%
    Sep 24
    		$0.60$0.08+650.00%Beat+306.9%
    Jun 24
    		$0.32$-0.11+390.91%Beat+178.0%
    Mar 24
    		$-0.34$-0.67+49.25%Beat+35.8%
    Dec 23
    		$0.49$-0.09+644.44%Beat+390.0%
    Sep 23
    		$-0.29$-0.57+49.12%Beat+51.7%
    Jun 23
    		$-0.41$-0.58+29.31%Beat+22.6%
    Mar 23
    		$-0.53$-0.70+24.29%Beat+13.1%
    Dec 22
    		$0.10N/A+118.52%Beat+211.1%
    Sep 22
    		$-0.60$-0.79+24.05%Beat-57.9%
    Jun 22
    		$-0.53$-0.63+15.87%Beat-10.4%
    Mar 22
    		$-0.61$-0.83+26.51%Beat-1.7%
    Dec 21
    		$-0.09N/A+80.43%Beat+67.9%
    Sep 21
    		$-0.38$-0.64+40.63%Beat+2.6%
    Jun 21
    		$-0.48$-0.66+27.27%Beat+45.5%
    Mar 21
    		$-0.60$-0.64+6.25%Beat+10.4%
    Dec 20
    		$-0.28$-0.48+41.67%Beat+26.3%
    Sep 20
    		$-0.39$-0.73+46.58%Beat-14.7%
    Jun 20
    		$-0.88$-1.14+22.81%Beat-175.0%
    Mar 20
    		$-0.67$-0.60-11.67%Miss-91.4%
    Dec 19
    		$-0.38$-0.40+5.00%Beat-72.7%
    Sep 19
    		$-0.34$-0.41+17.07%Beat-54.5%
    Jun 19
    		$-0.32$-0.43+25.58%Beat+25.6%
    Mar 19
    		$-0.35$-0.38+7.89%Beat+93.1%
    Dec 18
    		$-0.22$-0.31+29.03%Beat+93.6%
    Sep 18
    		$-0.22$-0.34+35.29%Beat+94.4%
    Jun 18
    		$-0.43$-0.48+10.42%Beat-
    Mar 18
    		$-5.05$-3.64-38.74%Miss-
    Dec 17
    		$-3.46$0.00N/AMiss-
    Mar 17
    		$-3.90$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio27.75EV/EBITDA17.01x
    Price/FCF15.51xFCF Yield6.45%
    Profitability
    Profit Margin15.00%Operating Margin-0.26%
    ROE18.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio8.55xQuick Ratio6.16x
    Trading Statistics
    Beta0.67Avg Volume656.33K
    52-Week High$147.0352-Week Low$38.91

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$61.23
    SMA 20$60.26
    SMA 50$53.41
    SMA 200$66.68
    EMA 10$61.05
    EMA 20$59.30
    EMA 50$55.24
    EMA 200$66.32

    MACD

    Line: 2.48Signal: 2.57Hist: -0.09

    ADX

    ADX: 32.3+DI: 29.7-DI: 11.5

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down4.0
    PSAR$57.96

    Bollinger Bands

    Upper Band$64.25
    Lower Band$56.28
    %B Position1322%(Upper)
    Band Width0.84

    RSI (14-Day)

    Neutral
    65.1

    Momentum Oscillators

    Stoch %K81.4
    Stoch %D77.4
    Williams %R-2.6
    ROC (10d)10.1%
    Momentum5.78
    CCI (20d)87.9
    MFI (14d)43.8

    Volatility Measures

    ATR (14d)$2.53(4.0%)
    StdDev (20d)1.99
    Hist Vol91.2%(High)

    Volume Flow

    VWAP$62.08
    OBV-13.8M
    AD Line4.8M
    CMF (20d)0.025

    Volume Metrics

    Avg Vol (20d)639.5K
    Vol Ratio0.8x
    VWMA (20d)$60.74

    Pivot Points

    R3$63.71
    R2$62.88
    R1$62.16
    Pivot Point$61.33
    S1$60.61
    S2$59.78
    S3$59.06

    Advanced Oscillators

    TSI25.59
    Ultimate Osc62.2
    KST173.40

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$200.58M$204.58M$269.08M$224.50M$217.09M$201.32M$239.72M$203.19M$195.88M$164.01M$192.51M$153.30M
    Cost of Revenue$29.12M$27.67M$36.07M$31.77M$34.67M$30.71M$35.99M$32.40M$29.84M$24.76M$28.05M$24.38M
    Gross Profit$171.46M$176.91M$233.01M$192.73M$182.41M$170.61M$203.73M$170.79M$166.04M$139.25M$164.45M$128.92M
    Operating Expenses$171.97M$178.03M$186.90M$183.08M$185.73M$172.09M$171.85M$156.47M$160.94M$154.47M$155.16M$142.39M
    R&D$24.70M$25.83M$24.94M$24.21M$26.21M$27.80M$30.34M$26.08M$28.86M$28.85M$31.05M$29.14M
    SG&A$147.28M$152.20M$161.95M$158.87M$159.52M$144.29M$141.51M$130.39M$132.08M$125.62M$124.11M$113.25M
    Operating Income$-514,000$-1,118,000$46.11M$9.64M$-3,316,000$-1,485,000$31.88M$14.32M$5.10M$-15,218,000$9.30M$-13,471,000
    Interest Income$3.74M$3.74M$4.00M$3.98M$4.48M$5.07M$5.55M$5.89M$5.88M$5.92M$5.87M$5.50M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$3.12M$2.40M$50.32M$13.55M$-2,332,000$4.16M$36.64M$20.33M$10.85M$-9,355,000$15.24M$-8,200,000
    Income Tax Expense$2.80M$13.69M$-85,771,000$3.62M$1.26M$1.17M$1.41M$1.83M$1.05M$650,000$477,000$340,000
    Net Income$314,000$-11,294,000$136.09M$9.93M$-3,592,000$2.99M$35.22M$18.50M$9.79M$-10,005,000$14.76M$-8,540,000
    EBITDA$3.74M$3.48M$49.89M$12.86M$-4,309,000$928,000$32.04M$13.88M$3.91M$-16,908,000$7.79M$-12,986,000
    EBIT$-624,000$-1,344,000$46.44M$9.58M$-6,814,000$-907,000$31.11M$14.44M$4.96M$-15,278,000$9.37M$-13,695,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INSP

    Government Contracts

    Gov Obligations (TTM)
    $4.12M
    Gov Obligations / Revenue
    0.4%
    Obligations YoY
    0.4%
    Active Awards
    151
    New Awards (TTM)
    151
    Avg Remaining Term
    2.7 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24226N0449Department of Veterans AffairsDepartment of Veterans Affairs$100503Apr 8, 2026
    36C24226N0576Department of Veterans AffairsDepartment of Veterans Affairs$100302May 29, 2026
    36C25926P0465Department of Veterans AffairsDepartment of Veterans Affairs$50195May 13, 2026
    36C25626N0583Department of Veterans AffairsDepartment of Veterans Affairs$50151Jun 11, 2026
    36C24226N0530Department of Veterans AffairsDepartment of Veterans Affairs$50151May 7, 2026
    36C24926F0066Department of Veterans AffairsDepartment of Veterans Affairs$50151Dec 23, 2025
    36C24226N0260Department of Veterans AffairsDepartment of Veterans Affairs$50151Nov 20, 2025
    36C24225P1403Department of Veterans AffairsDepartment of Veterans Affairs$49900Aug 21, 2025
    36C24526F0078Department of Veterans AffairsDepartment of Veterans Affairs$47337Oct 27, 2025
    36C25026N0434Department of Veterans AffairsDepartment of Veterans Affairs$43417Mar 26, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Inspire Medical Systems (INSP) holder to sell 64 shares in 2026

    John Rondoni, a shareholder of Inspire Medical Systems, Inc. (INSP), has filed a Rule 144 notice to sell 64 shares of common stock with an aggregate market value of $3,991.04. The shares, acquired through an employee stock purchase plan in 2023 and 2024, are planned to be sold through Morgan Stanley Smith Barney LLC on or about August 24, 2026, on the NYSE. The filing indicates a neutral impact and sentiment regarding the sale, with 28,910,375 shares of Inspire Medical Systems common stock currently outstanding.

    Stock Titan•8/24/26•
    Neutral

    Inspire Medical Systems (INSP) Stock Analysis: Navigating the Sleep Apnea Market with High Valuation and Mixed Ratings

    Inspire Medical Systems (INSP) is a prominent player in the sleep apnea market, noted for its innovative neurostimulation technology. The company faces a high valuation with a forward P/E of 40.57 and a recent 7.60% revenue downturn, though it maintains a strong 17.97% Return on Equity. Analyst ratings are mixed, with a majority recommending "hold" and an average target price slightly below its current trading price, indicating a cautious outlook despite promising technology.

    DirectorsTalk Interviews•8/24/26•
    Neutral

    Inspire Medical Systems Inc (INSP) News, Articles, Events & Latest Updates

    This article provides recent news and updates for Inspire Medical Systems Inc (INSP), highlighting its stock performance, growth drivers, and financial outlook. It notes that INSP stock has rallied significantly year-to-date due to easing reimbursement pressures and increased adoption of its Inspire V product. The company has also raised its 2026 outlook following a strong Q2 earnings beat, despite some lingering reimbursement challenges.

    Stocktwits•8/22/26•
    Bullish

    Inspire Medical Systems (INSP) Is Up 5.9% After Analysts Lift Earnings Forecasts And Zacks Upgrade

    Inspire Medical Systems (INSP) saw its stock rise by 5.9% after analysts increased their current-year earnings forecasts, leading to a Zacks Rank #1 (Strong Buy) upgrade. This positive shift in sentiment for the specialized medical technology firm comes despite ongoing risks like product recalls, reimbursement pressures, and alternative treatments. The article discusses Inspire's investment narrative, financial projections, and contrasting analyst perspectives, emphasizing the importance of individual research.

    Sahm•8/21/26•
    Somewhat-Bullish

    Here's Why You Should Add INSP Stock to Your Portfolio Now

    Inspire Medical Systems (INSP) is considered a strong buy due to its significant product transition and potential for growth in the underpenetrated obstructive sleep apnea (OSA) market. Despite a recent stock decline, the company is expanding its Inspire V system adoption, backed by strong clinical evidence and efforts to improve patient access. Challenges include reimbursement disruptions and potential pressure from GLP-1 therapies, but positive estimate revisions suggest a favorable outlook for 2026.

    TradingView•8/20/26•
    Bullish

    Frequently Asked Questions About INSP

    Does INSP pay dividends?
    Inspire Medical Systems Inc (INSP) does not currently pay a regular dividend.
    What is INSP's P/E ratio?
    Inspire Medical Systems Inc has a price-to-earnings (P/E) ratio of 27.75.
    What is INSP's market cap?
    Inspire Medical Systems Inc (INSP) has a market capitalization of $1.78B with a current stock price of $63.00.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In